DuPont de Nemours (NYSE:DD) Announces Earnings Results, Beats Expectations By $0.07 EPS

Key Points

• Beat expectations and raised guidance: DuPont reported Q1 adjusted EPS of $0.55 versus a $0.48 consensus and revenue of $1.68B, and raised Q2 guidance to $0.590 and FY 2026 adjusted EPS to $2.35–$2.40 (a $0.10 increase).
• Balance-sheet and capital returns: Management completed the Aramids divestiture (≈$1.1B net proceeds) and announced a $275M accelerated share repurchase under its $2B program while targeting ~2x leverage and opportunistic M&A.
• Operational momentum and risks: Organic sales rose ~2% and operating EBITDA improved to $414M (+15% YoY) with margin gains, but the company flagged ~ $300M of Middle East exposure (≈4% of sales) and delayed shipments (~$10M) that could exacerbate input‑cost pressure.

DuPont de Nemours (NYSE:DD - Get Free Report) posted its quarterly earnings results on Tuesday. The basic materials company reported $0.55 EPS for the quarter, beating the consensus estimate of $0.48 by $0.07, FiscalAI reports. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. DuPont de Nemours's revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.03 earnings per share. DuPont de Nemours updated its Q2 2026 guidance to 0.590-0.590 EPS and its FY 2026 guidance to 2.350-2.400 EPS.

Here are the key takeaways from DuPont de Nemours' conference call:

• Raised full‑year guidance after beating Q1; management now targets ~ $7.185B in net sales at the midpoint and adjusted EPS of $2.35–$2.40 (a $0.10 raise), citing stronger start to the year and Aramids interest income.
• Q1 outperformance — organic sales +2%, operating EBITDA $414M (+15% YoY) with a 24.6% margin (+230 bps), and adjusted EPS $0.55 (reported +53% YoY), driven by favorable mix and productivity gains.
• Bolt‑on capital returns and balance‑sheet action — completed the Aramids divestiture (≈$1.1B net proceeds) and announced a $275M accelerated share repurchase under the existing $2B program, while targeting ~2x leverage and opportunistic M&A.
• Middle East logistics and input‑cost risk — ~ $10M of Q1 Water shipments were delayed and total exposure to the region is ~ $300M (~4% of sales); management expects ~1% pricing/surcharges (~$90M) to offset input cost inflation but flags escalation risk if the conflict worsens.
• Strategic execution and growth drivers — Healthcare strength (high‑single‑digit organic growth), microelectronics/ion‑exchange tailwinds from AI/data‑center demand, new product launches, and an AI collaboration (Uncountable) support medium‑term growth and margin resilience.

DuPont de Nemours Stock Performance

Shares of DD stock opened at $48.49 on Tuesday. DuPont de Nemours has a 12 month low of $26.82 and a 12 month high of $52.66. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.42 and a quick ratio of 1.91. The firm has a market capitalization of $19.88 billion, a P/E ratio of -26.24, a P/E/G ratio of 1.60 and a beta of 1.02. The company's fifty day moving average price is $46.49 and its two-hundred day moving average price is $43.02.

DuPont de Nemours Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 29th. Investors of record on Friday, May 15th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, May 15th. This represents a $0.80 annualized dividend and a yield of 1.6%. DuPont de Nemours's payout ratio is -43.01%.

Institutional Trading of DuPont de Nemours

A number of hedge funds and other institutional investors have recently modified their holdings of DD. Brighton Jones LLC increased its holdings in DuPont de Nemours by 19.6% during the 4th quarter. Brighton Jones LLC now owns 5,012 shares of the basic materials company's stock worth $382,000 after purchasing an additional 822 shares during the last quarter. Empowered Funds LLC grew its position in shares of DuPont de Nemours by 8.9% during the first quarter. Empowered Funds LLC now owns 11,550 shares of the basic materials company's stock worth $863,000 after buying an additional 947 shares in the last quarter. Sivia Capital Partners LLC bought a new stake in shares of DuPont de Nemours in the second quarter worth $365,000. United Bank increased its stake in shares of DuPont de Nemours by 14.6% in the second quarter. United Bank now owns 18,816 shares of the basic materials company's stock worth $1,291,000 after buying an additional 2,396 shares during the last quarter. Finally, First Trust Advisors LP raised its holdings in DuPont de Nemours by 2.1% in the second quarter. First Trust Advisors LP now owns 200,444 shares of the basic materials company's stock valued at $13,749,000 after acquiring an additional 4,186 shares in the last quarter. 73.96% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Argus dropped their price objective on shares of DuPont de Nemours from $86.00 to $52.00 and set a "buy" rating for the company in a research report on Thursday, February 5th. Morgan Stanley upped their price target on shares of DuPont de Nemours from $44.00 to $52.00 and gave the stock an "equal weight" rating in a research report on Tuesday, April 28th. Wall Street Zen raised DuPont de Nemours to a "hold" rating in a research report on Saturday, January 10th. Deutsche Bank Aktiengesellschaft boosted their price objective on DuPont de Nemours from $46.00 to $58.00 and gave the stock a "buy" rating in a research note on Wednesday, February 18th. Finally, Weiss Ratings reaffirmed a "sell (d)" rating on shares of DuPont de Nemours in a research report on Friday, March 27th. Twelve analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, DuPont de Nemours has a consensus rating of "Moderate Buy" and a consensus price target of $54.57.

Key DuPont de Nemours News

Here are the key news stories impacting DuPont de Nemours this week:

• Positive Sentiment: Q1 beat on EPS and revenue — DuPont reported adjusted EPS of $0.55 vs. the $0.48 consensus and revenue of $1.68B (vs. ~$1.67B est.), showing modest top‑line growth and an earnings beat that helped lift the stock. Read More.
• Positive Sentiment: Raised guidance — management bumped Q2 EPS to $0.590 and FY 2026 EPS to $2.350–2.400, both above street estimates, and nudged revenue guidance (~$7.2B). Improved forward numbers support higher near‑term expectations for earnings. Read More.
• Positive Sentiment: $275M accelerated buyback — DuPont announced a $275 million accelerated repurchase, which reduces share count and signals management confidence in cash generation. Read More.
• Neutral Sentiment: Completed Aramids divestiture & cash flow — management closed the Aramids sale and reported positive operating cash flow and transaction‑adjusted free cash flow, supporting the buyback and guidance but also reflecting portfolio reshaping. Read More.
• Neutral Sentiment: ESG reporting — DuPont published its 2026 Sustainability Report with 2035 goals; positive for long‑term branding but not an immediate earnings driver. Read More.
• Negative Sentiment: Y/Y EPS decline and trailing profitability metrics — although Q1 returned to profit (GAAP income from continuing ops $150M), adjusted EPS is well below the prior‑year quarter and trailing metrics still show a negative net margin on some measures; valuation (historical P/E) and profitability durability remain investor concerns. Read More.
• Negative Sentiment: Mixed analyst view — brokers have rated the stock around a “moderate buy,” indicating upside expectations but not unanimous conviction. Read More.

About DuPont de Nemours

DuPont de Nemours NYSE: DD is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.